Abstract
The emergence and spread of carbapenem-hydrolysing beta-lactamases among Enterobacteriaceae and Non-fermentative Gram-negative bacilli organisms like Pseudomonas spp. or Acinetobacter baumannii over the past ten years is a serious problem in hospital settings. This problem has been exacerbated by the fact that carbapenems are no longer as effective against these pathogens. Aside from that, numerous bacteria in the natural environment form biofilms. When opportunistic biofilm-forming pathogens cause infections, they can cause severe symptoms in many cases and death in people who don't have strong immune systems. No new class of antibiotic have been reported in the last several decades. In this context, Recent years have seen a rise in the importance of nanobiotechnology in the production of nanomaterials that function as antibacterial agents. It is possible for nanoparticles to be active molecules or compounds that react with bacterial cells to kill them. This has the potential to resolve issues associated with multidrug resistance and inhibit biofilm. In the present study, synthesized ZnO nanoflakes were utilized. These nanoflakes had an average crystallite size of 21.5 ± 4.8 nm, a thickness of 20-50 nm, and different characteristics. We have included 67 Carbapenem resistant Enterobacteriaceae (CRE) and Non-fermentative Gram-negative bacilli isolates, which were isolated from various clinical samples. ZnO-NPs showed strong antibacterial and antibiofilm action against clinical isolates, according to growth kinetics and antibiofilm assay. In addition, we looked into how ZnO-NPs interact with clinical bacterial strains to determine their mode of action. ZnO is thought to exert its effects via reactive oxygen species (ROS) production, which boosts membrane lipid peroxidation and ultimately results in the loss of reducing sugars through membrane leakage. These findings suggest that in future ZnO-NPs might be an effective alternate treatment of choice to treat infections caused by CR bacterial isolates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.